The goals of imaging after neoadjuvant therapy for breast cancer are to monitor the
response to therapy and facilitate surgical planning. MRI has been found to be more …

Background Achieving pathological complete response (pCR) to neoadjuvant
chemotherapy (NAC) improves survival outcomes for breast cancer patients. Currently …

Neoadjuvant therapy is increasingly being used to treat early-stage triple-negative and
human epidermal growth factor 2–overexpressing breast cancers, as well as locally …

Purpose: Accurate response assessment during neoadjuvant systemic treatment (NST)
poses a clinical challenge. Therefore, a minimally invasive assessment of tumor response …

Background While several methods have been proposed for automated assessment of
breast‐cancer response to neoadjuvant chemotherapy on breast MRI, limited information is …

Objectives This study aimed to investigate the predictability of breast MRI for pathologic
complete response (pCR) by molecular subtype in patients with breast cancer receiving …

Purpose Neoadjuvant clinical trials with dual HER2 blockade with pertuzumab and
trastuzumab plus chemotherapy demonstrated high rates of pathological complete response …

The advancement in systemic neoadjuvant therapy has significantly increased the
pathological complete response (pCR) rate in breast cancer. As surgeries inevitably affect …

Background This study assessed whether magnetic resonance imaging (MRI) could
accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy …

Purpose To evaluate and compare the diagnostic performance of diffusion-weighted
imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in …